{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:57:02Z","timestamp":1764046622187,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81600134"],"award-info":[{"award-number":["81600134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yexcr.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T02:31:07Z","timestamp":1488681067000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nrf-2\/Gst-\u03b1 mediated imatinib resistance through rapid 4-HNE clearance"],"prefix":"10.1016","volume":"353","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanwu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.yexcr.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94","author":"Chereda","year":"2015","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.yexcr.2017.03.004_bib2","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yexcr.2017.03.004_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/10428190310001625755","article-title":"Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia","volume":"45","author":"Hofmann","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl 1","key":"10.1016\/j.yexcr.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2011.01.016","article-title":"Nilotinib: a novel, selective tyrosine kinase inhibitor","volume":"38","author":"Blay","year":"2011","journal-title":"Semin Oncol."},{"issue":"24","key":"10.1016\/j.yexcr.2017.03.004_bib5","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2009-04-214221","article-title":"Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations","volume":"114","author":"Muller","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yexcr.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ccr.2009.08.012","article-title":"Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way","volume":"16","author":"Strout","year":"2009","journal-title":"Cancer Cell."},{"issue":"3","key":"10.1016\/j.yexcr.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2004-05-2041","article-title":"Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells","volume":"105","author":"Guo","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yexcr.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/cdd.2013.138","article-title":"Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance","volume":"20","author":"Dalleau","year":"2013","journal-title":"Cell Death Differ."},{"issue":"Pt 4","key":"10.1016\/j.yexcr.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1242\/jcs.113.4.635","article-title":"4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death","volume":"113","author":"Liu","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2017.03.004_bib10","first-page":"873525","article-title":"4-Hydroxy-2-nonenal induces apoptosis by inhibiting AKT signaling in human osteosarcoma cells","volume":"2014","author":"Ji","year":"2014","journal-title":"Sci. J."},{"issue":"2","key":"10.1016\/j.yexcr.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.abb.2008.09.016","article-title":"4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells","volume":"480","author":"Sharma","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.yexcr.2017.03.004_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.taap.2015.10.006","article-title":"Antioxidant role of glutathione S-transferases: 4-hydroxynonenal, a key molecule in stress-mediated signaling","volume":"289","author":"Singhal","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"issue":"3\u20134","key":"10.1016\/j.yexcr.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/ars.2005.7.385","article-title":"Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation","volume":"7","author":"Kobayashi","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.yexcr.2017.03.004_bib15","first-page":"526","article-title":"Elevated expression of Nrf-2 and ABCG2 involved in multi-drug resistance of lung cancer SP cells","volume":"65","author":"Yang","year":"2015","journal-title":"Drug Res. (Stuttg.)."},{"key":"10.1016\/j.yexcr.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2012.12.014","article-title":"Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance","volume":"57","author":"Niture","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1096\/fj.14-262659","article-title":"Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment","volume":"29","author":"Venkatraman","year":"2015","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.yexcr.2017.03.004_bib18","article-title":"HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction","volume":"4","author":"Kang","year":"2014","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.yexcr.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.cellsig.2015.06.006","article-title":"Heat shock protein-70 neutralizes apoptosis inducing factor in Bcr\/Abl expressing cells","volume":"27","author":"Wang","year":"2015","journal-title":"Cell. Signal."},{"issue":"1\u20132","key":"10.1016\/j.yexcr.2017.03.004_bib20","first-page":"123","article-title":"Use of the \u03b3-H2AX assay to monitor DNA damage and repair in translational cancer research","volume":"327","author":"Ivashkevich","year":"2011","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.yexcr.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","article-title":"NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer","volume":"34","author":"Hayes","year":"2009","journal-title":"Trends Biochem. Sci."},{"issue":"44","key":"10.1016\/j.yexcr.2017.03.004_bib22","doi-asserted-by":"crossref","first-page":"33761","DOI":"10.1074\/jbc.M604748200","article-title":"Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate","volume":"281","author":"Kweon","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.yexcr.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1\u2013NRF2 interaction in non-small-cell lung cancer","volume":"3","author":"Singh","year":"2006","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.yexcr.2017.03.004_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-12-66","article-title":"Methylation of the KEAP1 gene promoter region in human colorectal cancer","volume":"12","author":"Hanada","year":"2012","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.yexcr.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jnutbio.2015.01.004","article-title":"Myrosinase-treated glucoerucin is a potent inducer of the Nrf2 target gene heme oxygenase 1 \u2014 studies in cultured HT-29 cells and mice \u2606","volume":"26","author":"Wagner","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"40","key":"10.1016\/j.yexcr.2017.03.004_bib26","doi-asserted-by":"crossref","first-page":"12253","DOI":"10.1021\/bi060780+","article-title":"Regulation of CD95 (Fas) expression and Fas-mediated apoptotic signaling in HLE B-3 cells by 4-hydroxynonenal","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.yexcr.2017.03.004_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2014.03.001","article-title":"Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment","volume":"72","author":"Zhao","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2017.03.004_bib28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yexcr.2017.03.004_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.leu.2405086","article-title":"Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors","volume":"22","author":"Konig","year":"2008","journal-title":"Leukemia"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:19:37Z","timestamp":1757996377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0014482717301106"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.03.004","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf-2\/Gst-\u03b1 mediated imatinib resistance through rapid 4-HNE clearance","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}